| |
|
Sentrx Announces Partnership with Thomson Scientific
Drug Safety Firm Will Incorporate Leading-Edge Literature Search Capabilities into
Service Offerings
|
Little Falls, NJ - April 11, 2005 - Sentrx, the leading provider of technology-enabled
services and solutions for global drug safety, announced today that it has signed an agreement with Thomson
Scientific's Custom Information ServicesSM group, a business of The Thomson Corporation, to deliver customized
literature searches for adverse events. Sentrx will offer these capabilities as part of its Value-Added
Services.
Regulatory authorities, including the US Food and Drug Administration (FDA) and the European Agency for the
Evaluation of Medicinal Products (EMEA), require biopharmaceutical and medical device companies to search
scientific and medical publications on a regular basis for any mention of adverse events associated with their
marketed products. If one is found, the case must be investigated and reported to the appropriate agencies.
The process is time-consuming and requires the skills of information specialists and healthcare professionals.
Thomson Scientific offers the most thorough and expedient method for literature review in the industry.
Custom Information Services analyzes over 10,800 journals in the Thomson Scientific database using
client-specific profiles, which contain information regarding a company's products, therapeutic areas
and other points of interest. Custom Information Service staff evaluate the initial results and identify
relevant articles based on the company's search criteria. An expert staff of information scientists then
index and prepare customized abstracts or annotations to a company's specifications. Custom Information
Services delivers the finished product in whatever format is necessary for upload into any proprietary
database, including physician or healthcare professional websites.
"Sentrx strives to optimize drug safety operations, and we have found that literature review is often
performed inefficiently in the pharmaceutical industry," said Joseph Albano, Chief Executive Officer of
Sentrx. "Our partnership with Thomson Scientific helps us deliver best-of-breed processes and technology
to our clients for an important practice in adverse event monitoring and reporting."
"Pharmacovigilance and safety groups appreciate the value that CIS brings to literature review," said Angus
Metcalfe, Vice President for Pharma Chem Sales, Thomson Scientific. "We are pleased to expand our offerings
to these clients to include the processing of adverse event cases identified during research related to their
products."
About Sentrx
Sentrx is a leading provider of technology-enabled solutions and services for global drug safety. Its mission
is to manage the safety risks associated with developing and marketing pharmaceuticals. Through its
multilingual Safety Response Center, Sentrx delivers a unique combination of highly skilled people,
exclusive technology, and best practices in drug safety monitoring. To learn more about Sentrx, please
visit their website at www.sentrx.com or call 1-888-399-8032, extension 261.
About The Thomson Corporation
The Thomson Corporation is a global leader in providing integrated information solutions to business and
professional customers. Thomson provides value-added information, software tools and applications to more
than 20 million users in the fields of law, tax, accounting, financial services, higher education, reference
information, corporate training and assessment, scientific research and healthcare. With operational
headquarters in Stamford, CT, Thomson has approximately 38,000 employees and provides services in approximately
130 countries. The Corporation's common shares are listed on the New York and Toronto stock exchanges
(NYSE: TOC; TSX: TOC).
Thomson Scientific information solutions can be found at www.thomson.com/scientific and include: ISI Web of
KnowledgeSM - facilitating discovery by offering seamless navigation to high-quality, multidisciplinary
journal (Web of Science®), patent (Derwent World Patents Index®), and Web content, evaluation tools, and
bibliographic management products (EndNote®); Thomson PharmaSM - an integrated information solution for
the pharmaceutical and biotechnology markets; Delphion®-providing access to full-text patent documents
from the world's leading patent authorities; Techstreet-offering a wide variety of engineering codes and
standards; and BIOSIS Previews ®-the world's most comprehensive reference database for life science
research. For more information, please contact Rodney Yancey, Manager, Corporate Communications, Thomson
Scientific by phoning +1 215 386-0100, ext. 1396, or by sending an email to rodney.yancey@thomson.com.
Contact:
Jill Notte
Director of Marketing
Sentrx
Overlook at Great Notch
150 Clove Road
Little Falls, NJ 07424
Phone: 973-812-7575 ext. 261
Fax: 973-812-9094
Website: www.sentrx.com
|
|
|
